1. Home
  2. HWBK vs ELDN Comparison

HWBK vs ELDN Comparison

Compare HWBK & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$38.33

Market Cap

253.0M

Sector

Finance

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.92

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
ELDN
Founded
1865
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.0M
291.8M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HWBK
ELDN
Price
$38.33
$3.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
14.8K
1.9M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
2.49%
N/A
EPS Growth
31.42
30.67
EPS
0.83
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.10
$1.35
52 Week High
$40.36
$4.60

Technical Indicators

Market Signals
Indicator
HWBK
ELDN
Relative Strength Index (RSI) 50.35 51.47
Support Level $33.09 $3.69
Resistance Level $40.36 $4.15
Average True Range (ATR) 1.10 0.23
MACD -0.09 -0.01
Stochastic Oscillator 38.84 34.65

Price Performance

Historical Comparison
HWBK
ELDN

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: